Workflow
Jinhe Biotechnology(002688)
icon
Search documents
农林牧渔行业资金流出榜:牧原股份、国联水产等净流出资金居前
Market Overview - The Shanghai Composite Index fell by 0.13% on July 9, with 17 out of the 28 sectors rising, led by Media and Agriculture, Forestry, Animal Husbandry, and Fishery, which increased by 1.35% and 0.65% respectively [2] - The sectors with the largest declines were Non-ferrous Metals and Basic Chemicals, which dropped by 2.26% and 0.85% respectively [2] Capital Flow Analysis - The main capital outflow from the two markets totaled 38.536 billion yuan, with only three sectors experiencing net inflows: Media (1.055 billion yuan), Retail (864 million yuan), and Construction Decoration (40.34 million yuan) [2] - The Electronic sector saw the largest net outflow, amounting to 7.789 billion yuan, followed by Non-ferrous Metals with 5.412 billion yuan [2] Agriculture, Forestry, Animal Husbandry, and Fishery Sector - The Agriculture, Forestry, Animal Husbandry, and Fishery sector rose by 0.65% despite a net capital outflow of 437 million yuan [3] - Out of 103 stocks in this sector, 40 stocks increased, with one hitting the daily limit, while 55 stocks declined [3] - The top three stocks with net inflows were Xinwufeng (31.4665 million yuan), Haida Group (28.3706 million yuan), and Juxing Agriculture (21.9941 million yuan) [3][4] Top Gainers and Losers in Agriculture, Forestry, Animal Husbandry, and Fishery - **Top Gainers**: - Xinwufeng: +0.65%, 4.20% turnover, 31.4665 million yuan inflow [4] - Juxing Agriculture: +0.76%, 4.49% turnover, 21.9941 million yuan inflow [4] - **Top Losers**: - Muyuan Foods: -3.27%, 1.81% turnover, 71.5922 million yuan outflow [5] - Guolian Aquatic Products: -1.76%, 8.74% turnover, 45.2607 million yuan outflow [5]
金河生物(002688) - 关于参加内蒙古辖区上市公司2025年投资者网上集体接待日活动的公告
2025-07-09 07:45
本公司及董事会全体人员保证公告内容真实、准确和完整,并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 证券代码:002688 证券简称:金河生物 公告编号:2025-062 金河生物科技股份有限公司 关于参加内蒙古辖区上市公司2025年投资者 网上集体接待日活动的公告 2025年7月9日 1 为进一步加强与投资者的互动交流,金河生物科技股份有限公司(以下简 称"公司")将参加由内蒙古证监局、内蒙古上市公司协会与深圳市全景网络 有限公司联合举办的"2025年内蒙古辖区上市公司投资者集体接待日活动", 现将相关事项公告如下: 本次活动将采用网络远程的方式举行,投资者可登录"全景路演"网站 (http://rs.p5w.net),或关注微信公众号:全景财经,或下载全景路演APP参 与本次互动交流,活动时间为2025年7月11日(周五)16:00-18:00。届时公司高 管将在线就公司2024年度业绩、公司治理、发展战略、经营状况、融资计划、 股权激励和可持续发展等投资者关心的问题,与投资者进行沟通与交流,欢迎 广大投资者踊跃参与! 特此公告。 金河生物科技股份有限公司 董 事 会 ...
金河生物: 监事会关于2023年限制性股票激励计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-07-07 16:23
Core Viewpoint - The supervisory board of Jinhe Biotechnology Co., Ltd. has reviewed and approved the conditions for the release of restricted stock under the 2023 Restricted Stock Incentive Plan, confirming compliance with relevant laws and regulations [1][3]. Summary by Sections Section 1: Review of Incentive Objects - The company meets the conditions for implementing the stock incentive plan as per the Management Measures and relevant regulations, confirming the eligibility of the incentive objects for the second release period and the first reserved grant period [1][2]. - The incentive objects for the current plan do not fall under any disqualifying conditions as outlined in the Management Measures [2]. Section 2: Approval of Release Conditions - The supervisory board has verified that the 70 initial incentive objects and 11 reserved incentive objects meet the conditions for the release of restricted stocks, with a total of 4,326,000 shares for the initial grant and 500,000 shares for the reserved grant approved for release [3]. Section 3: Repurchase and Cancellation of Restricted Stocks - The supervisory board has determined that 43 incentive objects did not fully meet performance targets, leading to the repurchase and cancellation of their unvested restricted stocks, totaling 2,100,000 shares [3][5]. - The repurchase price adjustment and the process for cancellation have been confirmed to comply with relevant regulations, ensuring no harm to the company or shareholders [4][5].
金河生物: 关于公司为全资子公司提供担保额度预计的公告
Zheng Quan Zhi Xing· 2025-07-07 16:23
Summary of Key Points Core Viewpoint - The company, Jinhe Biological Technology Co., Ltd., plans to provide a guarantee of up to 100 million yuan for its wholly-owned subsidiary, Inner Mongolia Jinhe Environmental Technology Co., Ltd., to support its financing needs, which exceeds 50% of the company's latest audited net assets [1][2]. Group 1: Guarantee Overview - The board of directors approved the guarantee proposal with a unanimous vote of 9 in favor [1]. - The maximum guarantee amount is set at 10 million yuan, which represents 4.45% of the company's audited net assets for 2024 [1][4]. - The guarantee will be a joint liability guarantee, with the actual amount and duration to be determined in the final guarantee contract [1]. Group 2: Approval Process - The guarantee must be submitted to the shareholders' meeting for special resolution approval and does not involve related transactions or require approval from relevant authorities [2]. - The effective period of the guarantee is 12 months from the date of the shareholders' meeting resolution [2]. Group 3: Financial Situation of the Guaranteed Party - Inner Mongolia Jinhe Environmental Technology Co., Ltd. is a wholly-owned subsidiary with a registered capital of 50 million yuan and an asset-liability ratio of 32.77% [3]. - The subsidiary's recent financial data shows a revenue of approximately 170.12 million yuan for 2024 and a net profit of about 33.14 million yuan [3]. Group 4: Board's Opinion - The board believes that providing this guarantee will meet the subsidiary's operational funding needs and support its healthy and sustainable development [3]. - The company has the ability to control operational and financial risks during the guarantee period, and this action aligns with the company's long-term interests [3]. Group 5: Cumulative Guarantee Situation - As of the announcement date, the total external guarantee balance of the company and its subsidiaries is approximately 513.73 million yuan, which is 22.87% of the company's audited net assets for 2024 [4]. - The new guarantee of 10 million yuan will increase this percentage to 4.45% [4].
金河生物: 关于增加公司2025年日常关联交易预计额度的公告
Zheng Quan Zhi Xing· 2025-07-07 16:23
关于增加公司 2025 年日常关联交易预计额度的公告 证券代码:002688 证券简称:金河生物 公告编号:2025-060 金河生物科技股份有限公司 金河生物科技股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召开 第六届董事会第二十五次会议、第六届监事会第二十次会议及 2025 年 5 月 23 日召开的 2024 年度股东大会审议通过了《关于公司 2025 年度日常关联交易预计 额度的议案》。公司及子公司 2025 年预计发生接受关联人内蒙古金河建筑安装 有限责任公司(以下简称"金河建安")提供劳务的基本建设项目及基建维修的 关联交易总额为不超过 5,720 万元。子公司及二级子公司 2025 年预计发生接受 关联人北京中业园净化空调工程有限公司(以下简称"北京中业园")提供劳务 的日常关联交易总额为不超过 517.50 万元。具体内容详见公司于 2025 年 4 月 会第二十五次会议决议公告》《第六届监事会第二十次会议决议公告》和 2025 年 5 月 24 日披露的《2024 年度股东大会决议的公告》。 本公司及董事会全体人员保证公告内容真实、准确和完整,并对公告中的虚 假记载、误 ...
金河生物: 北京市中伦(上海)律师事务所关于金河生物科技股份有限公司2023年限制性股票激励计划首次授予第二个解除限售期和预留授予第一个解除限售期解除限售条件成就、回购注销部分限制性股票及调整回购价格相关事项的法律意见书
Zheng Quan Zhi Xing· 2025-07-07 16:23
Core Viewpoint - The legal opinion letter from Beijing Zhonglun (Shanghai) Law Firm confirms the completion of the second unlock period for the initial grant of restricted stock and the first unlock period for reserved grants under the 2023 Restricted Stock Incentive Plan of Jinhe Biotechnology Co., Ltd, along with the repurchase and cancellation of certain restricted stocks and adjustments to the repurchase price [1][2][22]. Group 1: Unlock Conditions and Achievements - The second unlock period for the initial grant of restricted stocks is set to be 24 months after the registration completion date, which was completed on July 7, 2023 [13][14]. - The first unlock period for reserved grants is 12 months after the registration completion date, which was completed on December 28, 2023 [14]. - The company has met the performance assessment requirements for the unlock conditions, with a net profit growth rate of 88.29% in 2024, exceeding the required 78% [17][18]. Group 2: Repurchase and Price Adjustment - The company plans to repurchase and cancel a total of 2,100,000 shares of restricted stock due to the departure of certain incentive targets and performance failures [21][22]. - The adjusted repurchase price for the restricted stocks is set at 2.29 yuan per share, following a cash dividend distribution of 1.00 yuan per 10 shares [19][22]. - The repurchase will be funded by the company's own funds, and the repurchase reasons, quantity, price, and funding sources comply with relevant regulations [22].
金河生物: 关于2023年限制性股票激励计划首次授予第二个解除限售期及预留授予第一个解除限售期解除限售条件成就的公告
Zheng Quan Zhi Xing· 2025-07-07 16:23
Core Viewpoint - The company has announced the achievement of conditions for the first unlock period of the reserved stock grant and the second unlock period of the initial stock grant under the 2023 restricted stock incentive plan, allowing 71 incentive recipients to unlock a total of 4,826,000 shares, which represents 0.63% of the company's total share capital [1][2][18]. Summary by Relevant Sections Incentive Plan Overview - The 2023 restricted stock incentive plan initially granted 21,370,000 shares, accounting for approximately 2.74% of the company's total share capital at the time of the plan's announcement [2][11]. - The plan includes a reserved grant of 1,000,000 shares, representing 0.13% of the total share capital [2][11]. Unlock Conditions - A total of 71 incentive recipients are eligible for unlocking, with 70 recipients eligible for the second unlock period of the initial grant (4,326,000 shares) and 11 recipients eligible for the first unlock period of the reserved grant (500,000 shares) [1][2][18]. - The unlocking of shares is subject to the completion of necessary procedures by relevant authorities [1][2]. Performance Assessment - The performance assessment for the first unlock period requires a net profit growth rate of no less than 155% for 2023, based on the 2022 net profit [7][9]. - For the second unlock period, the required growth rate is 78% for 2024, and for the third unlock period, it is 131% for 2025 [9][10]. Compliance and Approval - The board of directors and the supervisory board have reviewed and approved the unlocking conditions, confirming compliance with relevant regulations and the company's articles of association [22][23]. - Legal opinions affirm that the necessary approvals and authorizations have been obtained for the unlocking of shares [24][25].
长鸿高科正在筹划购买广西长科100%股权 ;瑞斯康达董事长被采取刑事强制措施|公告精选
Mei Ri Jing Ji Xin Wen· 2025-07-07 14:31
Mergers and Acquisitions - Hangcha Group's subsidiary plans to increase capital and acquire approximately 99% of Guozhi Robotics [1] - Changhong High-Tech is planning to purchase 100% equity of Guangxi Changke through share issuance and cash payment, which is expected to constitute a major asset reorganization [2] Shareholding Changes - Newray's senior management plans to reduce their holdings by up to 0.3% of the company's shares due to personal financial needs [3] - Zhuoyi Information's employee shareholding platform intends to reduce its holdings by up to 1.88% of the company's shares due to employees' financial needs [4] - Baotong Technology's major shareholders plan to collectively reduce their holdings by up to 2.36% of the company's shares for personal financial reasons [5] Performance Disclosure - Huayou Cobalt expects a year-on-year increase of 56% to 68% in net profit attributable to shareholders for the first half of 2025, driven by integrated operations and rising cobalt prices [6] - Skyworth Digital anticipates a year-on-year decline of 76% to 65% in net profit attributable to shareholders for the first half of 2025 due to a significant drop in sales prices of smart terminal products [7] - Shandong Molong expects a year-on-year decline of 92% to 94% in net profit attributable to shareholders for the first half of 2025, primarily due to the previous year's asset sales [8][9] Investment Matters - Jinhe Biological's wholly-owned subsidiary plans to invest 158 million yuan in a wastewater treatment expansion project to enhance future profitability [10] Risk Matters - Risconda's chairman and a director have been subjected to criminal coercive measures due to allegations of information disclosure violations [11]
金河生物(002688) - 关于增加公司2025年日常关联交易预计额度的公告
2025-07-07 12:15
证券代码:002688 证券简称:金河生物 公告编号:2025-060 金河生物科技股份有限公司 关于增加公司 2025 年日常关联交易预计额度的公告 本公司及董事会全体人员保证公告内容真实、准确和完整,并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 一、日常关联交易基本情况 (一)前次日常关联交易预计情况 金河生物科技股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召开 第六届董事会第二十五次会议、第六届监事会第二十次会议及 2025 年 5 月 23 日召开的 2024 年度股东大会审议通过了《关于公司 2025 年度日常关联交易预计 额度的议案》。公司及子公司 2025 年预计发生接受关联人内蒙古金河建筑安装 有限责任公司(以下简称"金河建安")提供劳务的基本建设项目及基建维修的 关联交易总额为不超过 5,720 万元。子公司及二级子公司 2025 年预计发生接受 关联人北京中业园净化空调工程有限公司(以下简称"北京中业园")提供劳务 的日常关联交易总额为不超过 517.50 万元。具体内容详见公司于 2025 年 4 月 26 日披露的《关于公司 2025 年度日常关联交易 ...
金河生物(002688) - 关于公司为全资子公司提供担保额度预计的公告
2025-07-07 12:15
证券代码:002688 证券简称:金河生物 公告编号:2025-059 金河生物科技股份有限公司 关于公司为全资子公司提供担保额度预计的公告 本公司及董事会全体人员保证公告内容真实、准确和完整,并对公告中的虚 假记载、误导性陈述或者重大遗漏承担责任。 特别提示: 1、金河生物科技股份有限公司(以下简称"公司"、"金河生物")及子 公司累计对外担保金额(包含本次预计新增担保)超过公司最近一期经审计净资 产50%。 2、公司及子公司未对合并报表范围外的公司提供担保。 3、公司及子公司未发生逾期担保、涉及诉讼的担保及因担保被判决败诉而 应承担损失的情况。 一、担保情况概述 公司于2025年7月7日召开第六届董事会第二十七次会议,以9票同意,0票反 对,0票弃权审议通过了《关于公司为全资子公司提供担保额度预计的议案》。 为满足子公司正常生产经营的资金需求,公司拟为全资子公司内蒙古金河环保科 技有限公司(以下简称"金河环保")在金融机构申请融资时提供担保,担保最 高额度为不超过10,000万元,占公司2024年经审计归属于母公司所有者净资产的 比例为4.45%,担保方式为连带责任保证担保。实际担保金额及担保期限等以最 ...